FindTrial
Sign In

Study for the detection of circulating tumor cells in cancer prevention and treatment

Screening model establishment and epidemiological study of antibodies against Epstein-Barr virus and circulating tumor cells-based combination for the early detection of nasopharyngeal carcinoma in high-incidence areas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028776
Enrollment
Unknown
Registered
2020-01-03
Start date
2018-09-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

Case series:Nil

Sponsors

Wuzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 69 Years

Inclusion criteria

Inclusion criteria: The method of cluster sampling and self-control was used to screen NPC of 30 to 69-year-old people in daoshui town and Changzhou town, Changzhou District, Wuzhou City.

Exclusion criteria

Exclusion criteria: Patients with severe cardiovascular, cerebrovascular, liver, kidney and lung diseases, deaf mute, mental patients and pregnant women.

Design outcomes

Primary

MeasureTime frame
CTC;EBV;—

Countries

China

Contacts

Public ContactYonglin Cai

Wuzhou Red Cross Hospital

cylzen@163.com+86 0774-3823081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026